ChronoScale Holdings Corp (CHRN) SEC Filings & Earnings Calls
EquiReason read 19 ChronoScale Holdings Corp SEC filings in the last 12 months. Latest: 8-K on 2026-10-15 — Revenue $41.5M (+148% YoY), adjusted EBITDA $5.9M, net loss $26.4M. Secured 50 MW AI compute deployment with Microsoft, partnerships with Nutanix and Baseten, $328.2M prepayments, .
Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason
- Market cap
- 2.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 26 Oct, in 2 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
15 Oct 20268-K · 2.02Revenue $41.5M (+148% YoY), adjusted EBITDA $5.9M, net loss $26.4M. Secured 50 MW AI compute deployment with Microsoft, partnerships with Nutanix and Baseten, $328.2M prepayments, on track for $1B annualized run-rate revenue by Q3 2027.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2027 | $42M | +149% y/y |
| Net loss · Q1-2027 | $-26M | |
| Net loss per share · Q1-2027 | $-0.18 | |
| Adjusted EBITDA · Q1-2027 | $6M | |
| Cash and cash equivalents · 2026-08-31 | $15M | |
| Customer prepayments · 2026-09-30 | $328M |
Guidance
On track for $1 billion annualized run-rate revenue by calendar Q3 2027
Company raised revenue outlook to $1B annualized run-rate by Q3 2027, supported by customer prepayments and new contracts.
Risks flagged
Negative gross margin from hardware resale; cost growth outpacing revenue.
“Cost of revenues $45.6M vs revenue $41.5M; net loss widened to $26.4M.”
Dependence on a few large customers; concentration risk.
“Revenue primarily from a new customer; Microsoft deployment is a single large contract.”
14 Oct 202610-QCompany entered into GPU services agreements with two customers, including Microsoft, with aggregate contracted revenues of $2.7 billion, and completed sale of Legacy Ekso Business.open
Figures in the filing · each found in the filing text
| Revenue · Q1-2027 | $41M | +148% y/y |
| Net Loss · Q1-2027 | $-42M | +278% y/y |
| Cash and Equivalents · 2026-08-31 | $15M | |
| Deferred Revenue · 2026-08-31 | $164000.00 | |
| Adjusted EBITDA · Q1-2027 | $6M | -37% y/y |
Risks flagged
Going Concern Risk
“The Company had a working capital deficit of approximately $70.5 million as of August 31, 2026 which raised substantial doubt about the Company's ability to continue as a going concern.” · word for word
Financing Risk
“The deployment is subject in part to our ability to obtain financing and to satisfy customary development, construction and operational conditions and milestones.” · word for word
Customer Concentration Risk
“The Company had two customers with sales of approximately 44% and 56% of the Company's total revenue for the three months ended August 31, 2026.” · word for word
Execution Risk
“Failure to satisfy these conditions or meet these milestones could result in penalties or entitle the Company's customers to credits or to termination rights under such contractual arrangements.” · word for word
6 Oct 20268-K · 5.02Director and CEO of subsidiary resigned following sale of Ekso Bionics; received RSU award and $709,500 release payment; no disagreement cited.open
Risks flagged
Loss of key executive at subsidiary; but expected post-sale
“resignation in connection with sale of Ekso; no disagreement”
2 Oct 20268-K · 5.02, 5.03, 7.01ChronoScale announces expanded and new AI infrastructure contracts, projecting $1B annualized run-rate revenue by Q3 2027, and completes sale of Ekso Bionics unit to focus on core AI business.open
Figures in the filing · each found in the filing text
| annualized run-rate revenue · AI infrastructure · Q3-2027 | $1.00B |
Guidance
Annualized run-rate revenue of $1 billion by calendar Q3 2027
Company raises revenue outlook with $1B run-rate target, driven by AI infrastructure contract expansions.
Risks flagged
Revenue target subject to deployment, power, equipment, and capital risks.
“Achievement and timing of this contracted revenue remain subject to a number of risks and uncertainties, including the successful and timely deployment and commissioning of planned infrastructure capacity, availability of power and equipment, and the Company’s ability to access capital on acceptable terms, among other factors.” · word for word
25 Sep 2026DEF 14AProxy statement filed for annual meeting; board committed to divest Legacy Ekso Business; holding company restructuring completed.open
Risks flagged
Majority stockholder control risk
“As of the Record Date, Applied Parent (directly, and indirectly through its indirect wholly-owned subsidiary) beneficially owned 139,528,227 shares of our common stock, or approximately 95.8% of our voting securities.” · word for word
Related party transaction risk
“We have entered into a Management Advisory and Corporate Services Agreement... Applied Parent provides management advisory and corporate services to us including financial, managerial, operational, strategic, financing, acquisition, and divestiture-related advice.”
16 Sep 20268-K · 1.01ChronoScale Intermediate amends existing $2M term loan with B. Riley, extending maturity to November 12, 2026, and permitting sale of Guarantor.open
Risks flagged
Limited risk; routine debt amendment with no material change in terms.
“All other material terms remain unchanged.”
27 Aug 20268-K · 7.01, 8.01ChronoScale announces strategic partnership with Microsoft for 50 MW AI compute deployment, extended from 2 to 3 years, featuring NVIDIA GB300 NVL72 systems and liquid cooling.open
Risks flagged
Execution risk in deploying 50 MW AI compute infrastructure with advanced liquid cooling and NVIDIA GB300 systems
“The deployment will feature NVIDIA GB300 NVL72 systems and advanced liquid-cooling infrastructure designed for high-density AI workloads” · word for word
19 Aug 202610-KEntered two-year strategic partnership with Microsoft to deploy 50 MW of AI compute capacity.open
Figures in the filing · each found in the filing text
| Revenue · continuing operations · FY2026 | $72M | -15% y/y |
| Cost of revenues · continuing operations · FY2026 | $89M | -23% y/y |
| Net loss from continuing operations · continuing operations · FY2026 | $-49M | -32% y/y |
| Cash and cash equivalents · 2026-05-31 | $10M | +303% y/y |
Risks flagged
Customer concentration risk
“Revenue decrease was primarily due to the loss of a customer in December 2024.”
Financing risk for deployment
“The deployment is subject to our ability to obtain financing on favorable terms and other customary development, construction, and operational conditions and milestones.” · word for word
Going concern risk mitigated
“Management has concluded that substantial doubt about our ability to continue as a going concern is not raised.” · word for word
26 Jun 2026SC 13D/AApplied Digital Corporation provided a $100M line of credit to ChronoScale Corp for working capital.open
Risks flagged
Concentrated ownership risk
“the Reporting Person may be deemed to beneficially own 96.1% of the outstanding shares of the Issuer” · word for word
12 May 2026SC 13DApplied Digital Corporation acquired 97.5% of ChronoScale Corporation through a business combination and private placement, resulting in a change of control.open
Figures in the filing · each found in the filing text
| Beneficial Ownership Percentage · 2026-05-05 | 97.5% | |
| Private Placement Amount · 2026-05-05 | $16M |
Risks flagged
Controlled Company Governance Risk
“the Issuer is a "controlled company" within the meaning of Nasdaq's corporate governance standards” · word for word
28 Apr 202610-QQ1 2026 revenue fell 37% YoY, net loss widened to $6.9M, and management disclosed substantial doubt about going concern with cash only lasting into early Q3 2026.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $2M | -37% y/y |
| Gross Profit · Q1-2026 | $1M | -41% y/y |
| Gross Margin · Q1-2026 | 50.0% | |
| Net Loss · Q1-2026 | $7M | +138% y/y |
| Cash and Restricted Cash · 2026-03-31 | $4M | -50% y/y |
| Device Revenue · Q1-2026 | $1M | -46% y/y |
| Service and Support Revenue · Q1-2026 | $594000.00 | -16% y/y |
| Subscription Revenue · Q1-2026 | $68000.00 | -22% y/y |
| Backlog · 2026-03-31 | $556000.00 | |
| Deferred Revenue · 2026-03-31 | $3M | -9% y/y |
Risks flagged
Going Concern Risk
“Management currently estimates that the Company's cash on hand as of March 31, 2026 will fund its operations into the early part of the third quarter of 2026.” · word for word
Revenue Concentration Risk
“During the three months ended March 31, 2026, the Company had two customers with sales of 10% or more of the Company’s total revenue (16% and 15%).” · word for word
Bad Debt Risk
“During the three months ended March 31, 2026, the Company recorded $298 in bad debt expense primarily related to the specific identification of certain uncollectible balances from a single counterparty.” · word for word
Business Combination Failure Risk
“If the Business Combination is not consummated for any reason, the trading price of our common stock may decline, and we may also be subject to additional risks if the Business Combination is not completed.” · word for word
10 Apr 202610-K/AAmended 10-K filed to provide Part III information (executive compensation, director independence, beneficial ownership) that was not included in the original 10-K.open
Risks flagged
Low incentive payout signals weak operational performance
“Based on its evaluation of company-wide performance for each of the two performance periods, the Board of Directors recommended that incentive awards be granted based on achievement of the revenue, cash spend and milestone performance goals at the following levels of achievement: 0% for the first half of 2025 and 30% for the full-year performance period.” · word for word
Concentrated voting control via Series B Preferred
“Daniel Asher (3) 435,432 12.2% 2,926 50% 18.5% Hood River Capital Management LLC (4) 63,892 1.8% 2,926 50% 9.8%” · word for word
23 Feb 202610-KAnnual report filed with financial results and disclosure of a proposed business combination.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $13M | -29% y/y |
| Gross Profit · FY2025 | $7M | -28% y/y |
| Gross Margin · FY2025 | 53.0% | |
| Net Loss · FY2025 | $12M | +3% y/y |
| Cash and Cash Equivalents · 2025-12-31 | $1M | -74% y/y |
| Accumulated Deficit · 2025-12-31 | $262M | +5% y/y |
| Sales and Marketing Expense · FY2025 | $7M | -2% y/y |
| Research and Development Expense · FY2025 | $3M | -22% y/y |
| General and Administrative Expense · FY2025 | $10M | +14% y/y |
| Impairment Loss on Intangible Assets · FY2025 | $750000.00 |
Risks flagged
Going Concern
“management believes that substantial doubt exists about our ability to meet cash requirements 12 months from the issuance of such financial statements” · word for word
Business Combination Failure
“If the Business Combination is not consummated for any reason, the trading price of our common stock may decline” · word for word
Revenue Concentration
“We currently rely, and in the future will rely, on sales of our EksoNR, Ekso Indego Therapy and Ekso Indego Personal for a large portion of our revenue.” · word for word
Reimbursement Risk
“If we fail to manage the complex and lengthy reimbursement process, our business and operating results could be adversely affected.” · word for word
Supply Chain Disruption
“Shortages in the materials used to manufacture our products and supply chain disruptions, including as a result of changes in trade policies, could impact our future results.” · word for word
17 Feb 20268-K · 1.01, 2.02, 3.02, 3.03, 5.01, 5.02, 5.03Preliminary Q4 2025 revenue $3.0-3.1M vs $5.1M prior year (down ~40%); gross margin 52-53% vs 53%; cash $1.2M vs $6.5M; operating cash burn $4.3M vs $1.4M. Also entered a material definitive agreement (contribution/exchange) and issued unreearningsopen
Figures in the filing · each found in the filing text
| Cash and cash equivalents · 2025-12-31 | $1M | -82% y/y |
| Net cash used in operations · Q4-2025 | $4M | +207% y/y |
Risks flagged
Cash runway risk: only $1.2M cash with $4.3M quarterly burn, implying less than one quarter of liquidity without additional financing.
“Estimated cash as of December 31, 2025 was $1.2 million... For the fourth quarter of 2025, the Company used an estimated $4.3 million of net cash in operations.” · word for word
Revenue decline risk: ~40% year-over-year revenue drop signals potential demand loss or competitive pressure.
“Total revenue for the fourth quarter of 2025 is estimated to be in the range of $3.0 million to $3.1 million, compared to total revenue of $5.1 million for the fourth quarter of 2024.” · word for word
28 Oct 202510-QQ3 2025 results: revenue slightly up, gross margin improved, but net loss continues and going concern doubt is raised.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $4M | +2% y/y |
| Gross Profit · Q3-2025 | $3M | +15% y/y |
| Gross Margin · Q3-2025 | 60.0% | |
| Net Loss · Q3-2025 | $1M | -31% y/y |
| Cash and Cash Equivalents · 2025-09-30 | $3M | |
| Accumulated Deficit · 2025-09-30 | $258M | |
| Non-cancellable Backlog · 2025-09-30 | $3M | |
| Deferred Revenue · 2025-09-30 | $3M |
Risks flagged
Going Concern
“Management currently estimates that the Company's cash will fund its operations into the first quarter of 2026.” · word for word
Nasdaq Delisting
“The Reverse Stock Split was effected in order to raise the per share trading price of the Company's common stock above $1.00 and regain compliance with the Minimum Bid Price Requirement.” · word for word
Customer Concentration
“During the three months ended September 30, 2025, the Company had one customer with sales of 10% or more of the Company’s total revenue (41%)” · word for word
Dependence on Financing
“Management intends to raise funds through one or more financings in the near term in order to meet our cash requirements for the next 12 months.” · word for word
28 Oct 20258-K · 2.02Q3 2025 revenue $4.2M (+2% YoY, +105% QoQ), gross margin 60.3% (+680bps YoY), net loss improved 31% YoY to $1.4M; exploring strategic transactions including potential sale of business.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $4M | +2% y/y |
| Gross margin · Q3-2025 | 60.3% | |
| Net loss · Q3-2025 | $1M | -33% y/y |
| Cash and cash equivalents · 2025-09-30 | $3M |
Risks flagged
Cash position of $2.7M may be insufficient to fund operations without additional financing or strategic transaction.
“As of September 30, 2025, the Company had cash of $2.7 million.” · word for word
Strategic review process creates uncertainty; potential sale of business or acquisition of unrelated line of business introduces execution risk.
“exploring one or more strategic transactions ... may include the acquisition of a line of business that is in a different industry ... and/or the sale of all or substantially all of the Company’s current business.” · word for word
ChronoScale Holdings Corp — questions
- What did ChronoScale Holdings Corp file recently?
- 19 SEC filings in the last 12 months. Latest: 8-K on 2026-10-15 — Revenue $41.5M (+148% YoY), adjusted EBITDA $5.9M, net loss $26.4M. Secured 50 MW AI compute deployment with Microsoft, partnerships with Nutanix and Baseten, $328.2M prepayments, on track for $1B annualized run-rate revenue by Q3 2027.
Every figure on this page comes from ChronoScale Holdings Corp's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.